UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029406
Receipt number R000033593
Scientific Title A cross-sectional metabolomic profiling study of peripheral blood in patients with schizophrenia and autism spectrum disorder using mass spectrometry
Date of disclosure of the study information 2017/10/10
Last modified on 2019/06/26 21:30:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A cross-sectional metabolomic profiling study of peripheral blood in patients with schizophrenia and autism spectrum disorder using mass spectrometry

Acronym

A mass spectrometry study in patients with schizophrenia and autism spectrum disorder

Scientific Title

A cross-sectional metabolomic profiling study of peripheral blood in patients with schizophrenia and autism spectrum disorder using mass spectrometry

Scientific Title:Acronym

A mass spectrometry study in patients with schizophrenia and autism spectrum disorder

Region

Japan


Condition

Condition

schizophrenia and autism spectrum disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Not translated yet

Basic objectives2

Others

Basic objectives -Others

Not translated yet

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Not translated yet

Key secondary outcomes

Not translated yet


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Not translated yet

Key exclusion criteria

Not translated yet

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shinichiro
Middle name
Last name Nakajima

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-0016

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan

TEL

03-3353-1211(61857)

Email

shinichiro.l.nakajima@gmail.com


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Nakajima

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-0016

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan

TEL

03-3353-1211(61857)

Homepage URL


Email

shinichiro.l.nakajima@gmail.com


Sponsor or person

Institute

Keio University School of Medicine
Department of Neuropsychiatry

Institute

Department

Personal name



Funding Source

Organization

Not translated yet

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Department of Neuropsychiatry

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan

Tel

03-3353-1211

Email

shinichiro.l.nakajima@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 08 Month 26 Day

Date of IRB

2017 Year 12 Month 11 Day

Anticipated trial start date

2018 Year 08 Month 28 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not translated yet


Management information

Registered date

2017 Year 10 Month 03 Day

Last modified on

2019 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033593


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name